16.88MMarket Cap-3.87P/E (TTM)
0.120High0.120Low82.60KVolume0.120Open0.120Pre Close9.91KTurnover0.42552wk High0.07%Turnover Ratio140.64MShares0.03552wk Low-0.031EPS TTM14.02MFloat Cap25.000Historical HighLossP/E (Static)116.82MShs Float0.035Historical Low-0.03EPS LYR0.00%Amplitude--Dividend TTM-1.94P/B1Lot Size--Div YieldTTM
Hemostemix Inc Stock Forum
Hemostemix and FireFly Neuroscience's Brain Network Analytics (BNA(TM)) Engage to Complete Phase 1 Vascular Dementia Clinical Trial of ACP-01
Hemostemix (TSXV: HEM) and Firefly Neuroscience (NASDAQ: AIFF) have announced a collaboration to conduct a Phase 1 clinical trial studying ACP-01 as a treatment for vascular dementia. The trial will evaluate brain wave activity in up to 100 patients using Firefly's FDA-Cleared BNA™ platform.
The ...
No comment yet